Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002) (Q80355582)
Jump to navigation
Jump to search
scientific article published on 23 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002) |
scientific article published on 23 May 2007 |
Statements
Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002) (English)
Yasumasa Nishimura
Kazuhiko Nakagawa
Koji Takeda
Masahiro Tanaka
Yoshihiko Segawa
Kayoko Tsujino
Shunichi Negoro
Nobukazu Fuwa
Toyoaki Hida
Masaaki Kawahara
Nobuyuki Katakami
Keiko Hirokawa
Nobuyuki Yamamoto
Masahiro Fukuoka
Yutaka Ariyoshi